Fan B, Crews B C, Turko I V, Choay J, Zettlmeissl G, Gettins P
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146.
J Biol Chem. 1993 Aug 15;268(23):17588-96.
To determine the effects of differences in glycosylation on the structure and functional properties of recombinant human antithrombin (rHAT), we have characterized the properties of the recombinant protein overexpressed by baby hamster kidney cells. Three forms of rHAT, I-III, were isolated which differed in affinity for heparin. Form I had the lowest affinity and contained a high proportion of highly branched complex carbohydrate. Form II had higher affinity and contained both complex and high mannose-type chains. Form III had the highest affinity and was similar to form II in the type of carbohydrate present, but had a lower level of glycosylation, consistent with the absence of carbohydrate at one of the four glycosylation sites. 1H NMR spectra of plasma HAT and rHAT forms I-III suggested very similar protein structures for all forms. Heparin pentasaccharide produced almost identical NMR perturbation difference spectra. The only functional difference found was in the rates of inactivation of factor Xa. Forms II and III gave second order rate constants similar to that of plasma HAT, whereas form I gave a biphasic inhibition, with the first phase having a rate about four times that of the other forms. We conclude that carbohydrate heterogeneity does not alter the structure of the HAT polypeptide or the heparin-induced conformational change, but does affect the heparin affinity and can alter the rate of proteinase inhibition.
为了确定糖基化差异对重组人抗凝血酶(rHAT)结构和功能特性的影响,我们对幼仓鼠肾细胞过表达的重组蛋白特性进行了表征。分离出三种形式的rHAT,即I - III型,它们对肝素的亲和力不同。I型亲和力最低,含有高比例的高度分支的复合碳水化合物。II型亲和力较高,含有复合和高甘露糖型链。III型亲和力最高,在存在的碳水化合物类型上与II型相似,但糖基化水平较低,这与四个糖基化位点之一不存在碳水化合物一致。血浆HAT和rHAT I - III型的1H NMR光谱表明所有形式的蛋白质结构非常相似。肝素五糖产生几乎相同的NMR扰动差异光谱。发现的唯一功能差异在于因子Xa的失活速率。II型和III型的二级速率常数与血浆HAT相似,而I型表现出双相抑制,第一阶段的速率约为其他形式的四倍。我们得出结论,碳水化合物异质性不会改变HAT多肽的结构或肝素诱导的构象变化,但会影响肝素亲和力并可能改变蛋白酶抑制速率。